new

Get trending papers in your email inbox!

Subscribe

Daily Papers

byAK and the research community

Nov 19

A review of path following control strategies for autonomous robotic vehicles: theory, simulations, and experiments

This article presents an in-depth review of the topic of path following for autonomous robotic vehicles, with a specific focus on vehicle motion in two dimensional space (2D). From a control system standpoint, path following can be formulated as the problem of stabilizing a path following error system that describes the dynamics of position and possibly orientation errors of a vehicle with respect to a path, with the errors defined in an appropriate reference frame. In spite of the large variety of path following methods described in the literature we show that, in principle, most of them can be categorized in two groups: stabilization of the path following error system expressed either in the vehicle's body frame or in a frame attached to a "reference point" moving along the path, such as a Frenet-Serret (F-S) frame or a Parallel Transport (P-T) frame. With this observation, we provide a unified formulation that is simple but general enough to cover many methods available in the literature. We then discuss the advantages and disadvantages of each method, comparing them from the design and implementation standpoint. We further show experimental results of the path following methods obtained from field trials testing with under-actuated and fully-actuated autonomous marine vehicles. In addition, we introduce open-source Matlab and Gazebo/ROS simulation toolboxes that are helpful in testing path following methods prior to their integration in the combined guidance, navigation, and control systems of autonomous vehicles.

  • 9 authors
·
Apr 14, 2022

Adaptive Data Augmentation with NaturalSpeech3 for Far-field Speaker Verification

The scarcity of speaker-annotated far-field speech presents a significant challenge in developing high-performance far-field speaker verification (SV) systems. While data augmentation using large-scale near-field speech has been a common strategy to address this limitation, the mismatch in acoustic environments between near-field and far-field speech significantly hinders the improvement of far-field SV effectiveness. In this paper, we propose an adaptive speech augmentation approach leveraging NaturalSpeech3, a pre-trained foundation text-to-speech (TTS) model, to convert near-field speech into far-field speech by incorporating far-field acoustic ambient noise for data augmentation. Specifically, we utilize FACodec from NaturalSpeech3 to decompose the speech waveform into distinct embedding subspaces-content, prosody, speaker, and residual (acoustic details) embeddings-and reconstruct the speech waveform from these disentangled representations. In our method, the prosody, content, and residual embeddings of far-field speech are combined with speaker embeddings from near-field speech to generate augmented pseudo far-field speech that maintains the speaker identity from the out-domain near-field speech while preserving the acoustic environment of the in-domain far-field speech. This approach not only serves as an effective strategy for augmenting training data for far-field speaker verification but also extends to cross-data augmentation for enrollment and test speech in evaluation trials.Experimental results on FFSVC demonstrate that the adaptive data augmentation method significantly outperforms traditional approaches, such as random noise addition and reverberation, as well as other competitive data augmentation strategies.

  • 3 authors
·
Jan 14, 2025

Does Your Trial Simulator Know What the Drug Does? An Intervention-Blind Test of Interventional Validity on 7,207 Registered Trials

Patient world models are increasingly proposed as simulators of clinical trials, and recent surveys rank their capabilities on a ladder from temporal prediction to counterfactual rollouts. Position on that ladder is currently assigned by reading papers rather than by measurement. We turn the counterfactual rung into a measured quantity. From 30,119 completed phase 2/3 trials with results posted to ClinicalTrials.gov we construct 9,996 audited within-trial contrasts from 7,207 trials, and we score a simulator on how much of its accuracy depends on knowing which intervention was tested. The instrument is an intervention-blind reference: the same model, trained on the same trials, with every intervention-identifying field withheld. Interventional skill is the error the full model removes relative to that reference. On a temporal split (878 test contrasts from 655 trials) a registry-trained gradient-boosting simulator removes a fifth of the error of a trivial baseline, but its interventional skill is -0.12 (95% CI -0.21 to -0.05): withholding the intervention makes it better, and no alternative featurisation, stratum, temporal cut or same-molecule retrieval yields an interval above zero. A frontier language model reading only the registered protocol has interventional skill 0.20 [0.08, 0.31]; smaller and open-weight models sit at the limit of detection. Perturbation tests show the large model uses the intervention as such: swapping the arms reverses the sign of its prediction in 86% of contrasts. The blind reference is itself not drug-blind (a language model recovers the withheld drug class 45% of the time from the blind prompt), so interventional skill is a conservative lower bound. A reliability layer shows that ranking by predicted error lowers it but that calibrated error control does not transfer under temporal shift. Benchmark, code, prompts and per-call model outputs are released.

  • 1 authors
·
Nov 3

Panacea: A foundation model for clinical trial search, summarization, design, and recruitment

Clinical trials are fundamental in developing new drugs, medical devices, and treatments. However, they are often time-consuming and have low success rates. Although there have been initial attempts to create large language models (LLMs) for clinical trial design and patient-trial matching, these models remain task-specific and not adaptable to diverse clinical trial tasks. To address this challenge, we propose a clinical trial foundation model named Panacea, designed to handle multiple tasks, including trial search, trial summarization, trial design, and patient-trial matching. We also assemble a large-scale dataset, named TrialAlign, of 793,279 trial documents and 1,113,207 trial-related scientific papers, to infuse clinical knowledge into the model by pre-training. We further curate TrialInstruct, which has 200,866 of instruction data for fine-tuning. These resources enable Panacea to be widely applicable for a range of clinical trial tasks based on user requirements. We evaluated Panacea on a new benchmark, named TrialPanorama, which covers eight clinical trial tasks. Our method performed the best on seven of the eight tasks compared to six cutting-edge generic or medicine-specific LLMs. Specifically, Panacea showed great potential to collaborate with human experts in crafting the design of eligibility criteria, study arms, and outcome measures, in multi-round conversations. In addition, Panacea achieved 14.42% improvement in patient-trial matching, 41.78% to 52.02% improvement in trial search, and consistently ranked at the top for five aspects of trial summarization. Our approach demonstrates the effectiveness of Panacea in clinical trials and establishes a comprehensive resource, including training data, model, and benchmark, for developing clinical trial foundation models, paving the path for AI-based clinical trial development.

  • 5 authors
·
Jun 25, 2024

Image-based Treatment Effect Heterogeneity

Randomized controlled trials (RCTs) are considered the gold standard for estimating the average treatment effect (ATE) of interventions. One use of RCTs is to study the causes of global poverty -- a subject explicitly cited in the 2019 Nobel Memorial Prize awarded to Duflo, Banerjee, and Kremer "for their experimental approach to alleviating global poverty." Because the ATE is a population summary, anti-poverty experiments often seek to unpack the effect variation around the ATE by conditioning (CATE) on tabular variables such as age and ethnicity that were measured during the RCT data collection. Although such variables are key to unpacking CATE, using only such variables may fail to capture historical, geographical, or neighborhood-specific contributors to effect variation, as tabular RCT data are often only observed near the time of the experiment. In global poverty research, when the location of the experiment units is approximately known, satellite imagery can provide a window into such factors important for understanding heterogeneity. However, there is no method that specifically enables applied researchers to analyze CATE from images. In this paper, using a deep probabilistic modeling framework, we develop such a method that estimates latent clusters of images by identifying images with similar treatment effects distributions. Our interpretable image CATE model also includes a sensitivity factor that quantifies the importance of image segments contributing to the effect cluster prediction. We compare the proposed methods against alternatives in simulation; also, we show how the model works in an actual RCT, estimating the effects of an anti-poverty intervention in northern Uganda and obtaining a posterior predictive distribution over effects for the rest of the country where no experimental data was collected. We make all models available in open-source software.

TrialPanorama: Database and Benchmark for Systematic Review and Design of Clinical Trials

Developing artificial intelligence (AI) for vertical domains requires a solid data foundation for both training and evaluation. In this work, we introduce TrialPanorama, a large-scale, structured database comprising 1,657,476 clinical trial records aggregated from 15 global sources. The database captures key aspects of trial design and execution, including trial setups, interventions, conditions, biomarkers, and outcomes, and links them to standard biomedical ontologies such as DrugBank and MedDRA. This structured and ontology-grounded design enables TrialPanorama to serve as a unified, extensible resource for a wide range of clinical trial tasks, including trial planning, design, and summarization. To demonstrate its utility, we derive a suite of benchmark tasks directly from the TrialPanorama database. The benchmark spans eight tasks across two categories: three for systematic review (study search, study screening, and evidence summarization) and five for trial design (arm design, eligibility criteria, endpoint selection, sample size estimation, and trial completion assessment). The experiments using five state-of-the-art large language models (LLMs) show that while general-purpose LLMs exhibit some zero-shot capability, their performance is still inadequate for high-stakes clinical trial workflows. We release TrialPanorama database and the benchmark to facilitate further research on AI for clinical trials.

  • 9 authors
·
May 21, 2025

From Given to Gathered Evidence: Agentic Learning for Longitudinal Medical Reasoning

Foundation models can serve as clinical agents through tool-use harnesses. However, conventional medical benchmarks assess reasoning over preselected evidence rather than the ability to seek it across clinical records and longitudinal imaging. We propose CASE: a series of role-specific Clinical Agents for Seeking Evidence, together with a tool-use harness and an agentic post-training framework for compact vision-language policy models. We further introduce a longitudinal multimodal benchmark built on UK Biobank, comprising 50,401 clinical questions derived from real-world ICD-10-coded diagnoses of 4,739 participants. Each question links to a patient-specific environment containing clinical context and multi-sequence MRI from baseline and follow-up visits, where agents autonomously select which visits, organs, modalities, slices, and specialist tools to inspect and compare. Supervised fine-tuning transfers evidence-seeking workflows from 14,734 frontier-model interaction trajectories, followed by agentic reinforcement learning on the learner's own environment interactions. Privileged on-policy self-distillation and rubric-based LLM feedback refine evidence-to-conclusion reasoning without prescribing tool sequences. Experiments show that CASE moves beyond question-answer imitation toward transferable investigation policies, strengthening evidence-grounded longitudinal reasoning. Under matched evaluation conditions, our Qwen3-VL-8B based agent achieves over 16% and 10% relative improvements in answer accuracy over GPT-5.4 and Claude Opus 4.8. Code will be available at https://github.com/VinyehShaw/CASE.

CASE-Bench CASE
·
Sep 29 2

Technical Report on the Turba Fertilizer Machine Learning Stack in Morocco

Site-specific fertilizer recommendation systems adapt nutrient advice to location, soil properties, crop type, and production targets, but scientific reuse is constrained when recommendation functions remain accessible mainly through interactive interfaces, outputs are not versioned, and trained approximations cannot be independently loaded or benchmarked. This technical report presents the Turba fertilizer machine learning stack, a three-layer open-source implementation for reproducible site-specific fertilizer recommendation in Morocco. turba-client provides programmatic access to publicly accessible site profiles, crop-specific target-yield spaces, and N, P_2O_5, and K_2O recommendation workflows; turba-data distributes analysis-ready snapshots; and turba-models packages crop-specific machine learning surrogates of recommendation outputs. The architecture links upstream retrieval, versioned analytical snapshots, reproducible cross-model benchmarking, and loadable offline surrogates while preserving the distinction between recommendation-system outputs, observed agricultural data, and model-generated predictions. The first dataset was constructed from 44,096 unique ESA WorldCereal locations. Scenario expansion across supported cereal workflows generated 132,017 crop-location recommendation requests under a medium target-yield setting. The resulting 22-variable dataset spans 10 regions, 66 provinces, and 1,149 communes. Nine regression families were evaluated under a fixed deterministic 80/20 protocol, and the current release packages five best-performing crop-specific models. The machine learning task is recommendation-function emulation rather than prediction of observed crop response. The stack provides a reproducible basis for spatial and temporal validation, uncertainty estimation, field-trial comparison, and future integration with additional data.

Auto Research with Specialist Agents Develops Effective and Non-Trivial Training Recipes

We study auto research as a closed empirical loop driven by external measurement. Each submitted trial carries a hypothesis, an executable code edit, an evaluator-owned outcome, and feedback that shapes the next proposal. The output is not a generated paper or a single model checkpoint, but an auditable trajectory of proposals, code diffs, experiments, scores, and failure labels. We instantiate this loop with specialist agents that partition recipe surfaces and share measured lineage across trials. The central empirical finding is that lineage feedback lets agents turn evaluator outcomes, including crashes, budget overruns, size failures, and accuracy-gate misses, into later program-level recipe edits rather than one-shot suggestions. Across 1,197 headline-run trials plus 600 Parameter Golf control trials after one-time setup and launch, humans did not choose proposals, edit recipes, override scores, or repair failed trials during the search. In the three headline runs, the same submitted-trial loop reduces Parameter Golf validation bpb by 0.81%, raises NanoChat-D12 CORE by 38.7%, and reduces CIFAR-10 Airbench96 wallclock by 4.59%, with each task measured by its own external evaluator and legality checks. The trace includes a strict architecture-domain audit of 157 headline-run submissions and program rewrites such as a NanoChat attention-kernel path change. Within this scope the loop autonomously writes code, submits experiments, absorbs feedback, applies and combines known techniques inside each environment, and improves public starting recipes.

PRISM: Patient Records Interpretation for Semantic Clinical Trial Matching using Large Language Models

Clinical trial matching is the task of identifying trials for which patients may be potentially eligible. Typically, this task is labor-intensive and requires detailed verification of patient electronic health records (EHRs) against the stringent inclusion and exclusion criteria of clinical trials. This process is manual, time-intensive, and challenging to scale up, resulting in many patients missing out on potential therapeutic options. Recent advancements in Large Language Models (LLMs) have made automating patient-trial matching possible, as shown in multiple concurrent research studies. However, the current approaches are confined to constrained, often synthetic datasets that do not adequately mirror the complexities encountered in real-world medical data. In this study, we present the first, end-to-end large-scale empirical evaluation of clinical trial matching using real-world EHRs. Our study showcases the capability of LLMs to accurately match patients with appropriate clinical trials. We perform experiments with proprietary LLMs, including GPT-4 and GPT-3.5, as well as our custom fine-tuned model called OncoLLM and show that OncoLLM, despite its significantly smaller size, not only outperforms GPT-3.5 but also matches the performance of qualified medical doctors. All experiments were carried out on real-world EHRs that include clinical notes and available clinical trials from a single cancer center in the United States.

  • 13 authors
·
Apr 23, 2024 1

Bayesian aggregation of average data: An application in drug development

Throughout the different phases of a drug development program, randomized trials are used to establish the tolerability, safety, and efficacy of a candidate drug. At each stage one aims to optimize the design of future studies by extrapolation from the available evidence at the time. This includes collected trial data and relevant external data. However, relevant external data are typically available as averages only, for example from trials on alternative treatments reported in the literature. Here we report on such an example from a drug development for wet age-related macular degeneration. This disease is the leading cause of severe vision loss in the elderly. While current treatment options are efficacious, they are also a substantial burden for the patient. Hence, new treatments are under development which need to be compared against existing treatments. The general statistical problem this leads to is meta-analysis, which addresses the question of how we can combine datasets collected under different conditions. Bayesian methods have long been used to achieve partial pooling. Here we consider the challenge when the model of interest is complex (hierarchical and nonlinear) and one dataset is given as raw data while the second dataset is given as averages only. In such a situation, common meta-analytic methods can only be applied when the model is sufficiently simple for analytic approaches. When the model is too complex, for example nonlinear, an analytic approach is not possible. We provide a Bayesian solution by using simulation to approximately reconstruct the likelihood of the external summary and allowing the parameters in the model to vary under the different conditions. We first evaluate our approach using fake-data simulations and then report results for the drug development program that motivated this research.

  • 6 authors
·
May 12, 2020